The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease

被引:94
|
作者
Song, Myeong Jun [1 ,2 ]
Malhi, Harmeet [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
Nonalcoholic steatohepatitis; Lipotoxicity; Endoplasmic reticulum stress; Palmitate; Sphingolipids; ENDOPLASMIC-RETICULUM-STRESS; QUALITY-CONTROL PROTEINS; GROWTH-FACTOR; 21; ER-STRESS; TRANSCRIPTION FACTOR; URSODEOXYCHOLIC ACID; NONALCOHOLIC STEATOHEPATITIS; TAUROURSODEOXYCHOLIC ACID; MESSENGER-RNAS; TRANSMEMBRANE PROTEIN;
D O I
10.1016/j.pharmthera.2019.107401
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nonalcoholic fatty liver disease is a major public health burden. Although many features of nonalcoholic fatty liver disease pathogenesis are known, the specific mechanisms and susceptibilities that determine an individual's risk of developing nonalcoholic steatohepatitis versus isolated steatosis are not well delineated. The predominant and defining histologic and imaging characteristic of nonalcoholic fatty liver disease is the accumulation of lipids. Dysregulation of lipid homeostasis in hepatocytes leads to transient generation or accumulation of toxic lipids that result in endoplasmic reticulum (ER) stress with inflammation, hepatocellular damage, and apoptosis. ER stress activates the unfolded protein response(UPR)which is classically viewed as an adaptive pathway to maintain protein folding homeostasis. Recent studies have uncovered the contribution of the UPR sensors in the regulation of hepatic steatosis and in the cellular response to lipotoxic stress. Interestingly, theUPR sensors can be directly activated by toxic lipids, independently of the accumulation of misfolded proteins, termed lipotoxic and proteotoxic stress, respectively. The dual function of the UPR sensors in protein and lipid homeostasis suggests that these two types of stress are interconnected likely due to the central role of the ER in protein folding and trafficking and lipid biosynthesis and trafficking, such that perturbations in either impact the function of the ER and activate the UPR sensors in an effort to restore homeostasis. The precise molecular similarities and differences between proteotoxic and lipotoxic ER stress are beginning to be understood. Herein, we provide an overview of the mechanisms involved in the activation and cross-talk between the UPR sensors, hepatic lipid metabolism, and lipotoxic stress, and discuss the possible therapeutic potential of targeting the UPR in nonalcoholic fatty liver disease. (C) 2019 Published by Elsevier Inc.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Hepatic protein Carbonylation profiles induced by lipid accumulation and oxidative stress for investigating cellular response to non-alcoholic fatty liver disease in vitro
    Chienwichai, Peerut
    Reamtong, Onrapak
    Boonyuen, Usa
    Pisitkun, Trairak
    Somparn, Poorichaya
    Tharnpoophasiam, Prapin
    Worakhunpiset, Suwalee
    Topanurak, Supachai
    PROTEOME SCIENCE, 2019, 17 (1)
  • [42] Hepatic protein Carbonylation profiles induced by lipid accumulation and oxidative stress for investigating cellular response to non-alcoholic fatty liver disease in vitro
    Peerut Chienwichai
    Onrapak Reamtong
    Usa Boonyuen
    Trairak Pisitkun
    Poorichaya Somparn
    Prapin Tharnpoophasiam
    Suwalee Worakhunpiset
    Supachai Topanurak
    Proteome Science, 17
  • [43] INSULIN RESISTANCE, LIPID METABOLISM AND FATTY ACID PROFILE IN CHILDREN WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Janczyk, W.
    Wierzbicka, A.
    Socha, P.
    Neuhoff-Murawska, J.
    Lembas, A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E152 - E153
  • [44] Lingonberry Improves Non-Alcoholic Fatty Liver Disease by Reducing Hepatic Lipid Accumulation, Oxidative Stress and Inflammatory Response
    Madduma Hewage, Susara
    Prashar, Suvira
    Karmin, O.
    Siow, Yaw L.
    ANTIOXIDANTS, 2021, 10 (04)
  • [45] INFLUENCE OF LIVER FIBROSIS ON LIPID METABOLISM IN PATIENTS WITH ARTERIAL HYPERTENSION AND NON-ALCOHOLIC FATTY LIVER DISEASE
    Antyukh, Karina
    Grigorenko, Elena
    Mitkovskaya, Natalya
    JOURNAL OF HYPERTENSION, 2024, 42
  • [46] A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
    Rieger, Theodore R.
    Allen, Richard J.
    Musante, Cynthia J.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
    Rieger, Theodore R.
    Allen, Richard J.
    Musante, Cynthia J.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [48] Exposure to environmental contaminants is associated with sex-specific disturbances of hepatic lipid metabolism in non-alcoholic fatty liver disease
    Oresic, Matej
    Sen, Partho
    Quadri, Sami
    Luukkonen, Panu
    Ragnarsdottir, Oddny
    Jantti, Sirkku
    Juuti, Anne
    Arola, Johanna
    Yki-Jarvinen, Hannele
    Hyotylainen, Tuulia
    JOURNAL OF HEPATOLOGY, 2021, 75 : S605 - S606
  • [49] Regulation of lipid metabolism by the unfolded protein response
    Moncan, Matthieu
    Mnich, Katarzyna
    Blomme, Arnaud
    Almanza, Aitor
    Samali, Afshin
    Gorman, Adrienne M.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1359 - 1370
  • [50] How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
    Geng, Yana
    Faber, Klaas Nico
    de Meijer, Vincent E.
    Blokzijl, Hans
    Moshage, Han
    HEPATOLOGY INTERNATIONAL, 2021, 15 (01) : 21 - 35